| Cosentyx |
125504 |
003 |
351(a) |
secukinumab |
For Injection |
Subcutaneous |
150MG |
Single-Dose Vial |
2015/01/21
|
Novartis Pharmaceuticals Corporation |
Disc |
Licensed |
N/A |
N/A |
| Keytruda |
125514 |
002 |
351(a) |
pembrolizumab |
Injection |
Intravenous |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
2015/01/15
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
N/A |
N/A |
| Neulasta Onpro |
125031 |
002 |
351(a) |
pegfilgrastim |
Injection |
Subcutaneous |
6MG/0.6ML |
Pre-Filled Syringe |
2014/12/23
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Opdivo |
125554 |
001 |
351(a) |
nivolumab |
Injection |
Intravenous |
40MG/4ML (10MG/ML) |
Single-Dose Vial |
2014/12/22
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Opdivo |
125554 |
002 |
351(a) |
nivolumab |
Injection |
Intravenous |
100MG/10ML (10MG/ML) |
Single-Dose Vial |
2014/12/22
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
008 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intradermal |
36UG/.5ML |
Pre-Filled Syringe |
2014/12/11
|
Sanofi Pasteur Inc. |
Disc |
Licensed |
|
N/A |
| Gardasil 9 |
125508 |
001 |
351(a) |
Human Papillomavirus 9-valent Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2014/12/10
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Gardasil 9 |
125508 |
002 |
351(a) |
Human Papillomavirus 9-valent Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Single-dose vial |
2014/12/10
|
Merck Sharp & Dohme LLC |
Rx |
Licensed |
|
N/A |
| Blincyto |
125557 |
001 |
351(a) |
blinatumomab |
For Injection |
Intravenous |
35MCG |
Single-Dose Vial |
2014/12/03
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lemtrada |
103948 |
002 |
351(a) |
alemtuzumab |
Injection |
Intravenous |
12MG/1.2ML (10MG/ML) |
Single-Dose Vial |
2014/11/14
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |
| Trumenba |
125549 |
001 |
351(a) |
Meningococcal Group B Vaccine |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2014/10/29
|
Wyeth Pharmaceuticals LLC |
Rx |
Licensed |
|
N/A |
| Obizur |
125512 |
001 |
351(a) |
Antihemophilic Factor (Recombinant), Porcine Sequence |
For Injection |
Intravenous |
500U |
Single-Dose Vial |
2014/10/23
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Varizig |
125430 |
002 |
351(a) |
Varicella Zoster Immune Globulin (Human) |
Injection |
Intramuscular |
125IU |
Single-Dose Vial |
2014/09/29
|
Kamada Ltd. |
Rx |
Licensed |
|
N/A |
| Humira |
125057 |
005 |
351(a) |
adalimumab |
Injection |
Subcutaneous |
10MG/0.2ML |
Pre-Filled Syringe |
2014/09/23
|
AbbVie Inc. |
Disc* |
Licensed |
N/A |
N/A |
| Trulicity |
125469 |
001 |
351(a) |
dulaglutide |
Injection |
Subcutaneous |
0.75MG/0.5ML |
Autoinjector |
2014/09/18
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Trulicity |
125469 |
002 |
351(a) |
dulaglutide |
Injection |
Subcutaneous |
1.5MG/0.5ML |
Autoinjector |
2014/09/18
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Trulicity |
125469 |
003 |
351(a) |
dulaglutide |
Injection |
Subcutaneous |
0.75MG/0.5ML |
Pre-Filled Syringe |
2014/09/18
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Trulicity |
125469 |
004 |
351(a) |
dulaglutide |
Injection |
Subcutaneous |
1.5MG/0.5ML |
Pre-Filled Syringe |
2014/09/18
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Hyqvia |
125402 |
001 |
351(a) |
Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase |
Injection |
Subcutaneous |
0.1 |
Bottle |
2014/09/12
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Keytruda |
125514 |
001 |
351(a) |
pembrolizumab |
For Injection |
Intravenous |
50MG |
Single-Dose Vial |
2014/09/04
|
Merck Sharp & Dohme LLC |
Disc |
Licensed |
N/A |
N/A |